Fibrous dysplasia (FD) is a rare osseous pathology of unknown origin in which normal bone is replaced by fibro-osseous tissue. Recent research has linked FD to a somatic mutation in the protein transcription of the GNAS1 gene, which leads to an increase in intracellular cyclic adenosine monophosphate. FD represents 3% of all bony tumors and over 7% of all non-malignant bone tumors. FD has various clinical presentation groups such as the monostotic, craniofacial and polyostotic forms, and the McCune-Albright syndrome. We present a craniofacial FD case of a 45-year-old female patient, who underwent surgical treatment many times.
INTRODUCTION
Fibrous Dysplasia (FD) is a relatively rare osseous disease of unknown etiology, where the normal bone is changed by fibrous tissue, bony metaplasia and newly formed poorly calcified bone. The majority of FD cases are found between 10-30 years old, has the same prevalence rate in males and females and shows variable radiographic features in relation with the level of maturation, which determines of the imaging characteristics. FD can be monostotic or, more rarely, polyostotic. Affectation of the head osseous architecture, result in an evident cosmetic abnormally. The treatment of craniofacial FD should be focused on the relief of aesthetics and functional problems.
CASE REPORT
We present a craniofacial FD case of a 45-year-old female patient, without family medical history, who underwent surgical treatment from 15 years ago. The periodical CT scan control, in bone window, revealed a craniofacial expansive bones lesions with heterogeneous density. The right ethmoid and maxillary sinuses had been totally occuped (see Figures  1-2) . Additionally curved reformation of CT and 3D osseous volume rendering were created (see Figure 3) . Clinically, a great facial deformity was observed, with some neurological symptoms like atypical facial pain and local lumps.
In addition, MRI was performed, showing an expansive process, well delimited, T1-weighted MRI showed a mildly hypointense, solid mass centered in the right craniofacial region, not observed intracranial invasion. T2-weighted MRI showed a mildly hyperintense mass, invading the right orbit with anterior and lateral displacement of the globe. Heterogeneous avid enhancement of the mass was seen in the post contrast fat-saturated images (see Figure 4) . Microscopically the lesion revealed of a spread of spindle shaped cells, neoformation of osteoid and bone trabeculae. The trabeculae of woven bone had a variable pattern of distribution, localization and morphology (see Figure 5 ).
After evaluation, the Head and Neck Cancer Committee recommended periodic control mainly to prevent major vision complications.
DISCUSSION
FD is a noninherited rare osseous pathology of unknown origin where the normal bone is superseded by fibro-osseous tissue. [1, 2] FD and McCune-Albright syndrome (MAS) arises from activating missense mutations of the GNAS gene, which encodes the α-subunit of the Gs stimulatory protein (Gsα). Mutations occur post-zygotically resulting in a mosaic pattern of disease were shown to dramatically upregulate RANKL expression, consistent with the increased levels of osteoclastogenesis (RANKL promotes osteoclast differentiation and ultimately leads to increased bone resorption). [3, 17] FD represents 3% of all bony tumors and over 7% of all benign osseous tumors.
[4] Figure 5 . H&E Staint 20×: hypercellular fibrous stroma in which some areas of bone FD has various clinical presentation groups such as the monostotic, craniofacial and polyostotic forms, and the McCune-Albright syndrome. Monostotic FD involves a single bone and represent 80%-85% of all patients with FD; generally affects the long bones but frequently involves the skull (10%-20% of the patients). The rate of incidence is more highest in the maxilla that in the mandible. [1, 5] Craniofacial FD is restricted to the skull bones and ocular complications, such as visual loss, diplopia, and proptosis, occur in 20%-35% of the cases. [1] Polyostotic FD affects many bones, is relatively rare, and in some cases, is called the Jaffe type. When it observed, in the polyostotic form, cutaneous pigmentation, no regulated hyperfunction of one or many endocrine glands, we are in presence of the McCune-Albright syndrome. [1, 6, 7] More frequently the FD, was observed in patient between 10 and 30 years old, with equal sex distribution rate; however, the McCune-Albright syndrome is more common in females. [2] Microscopically FD shows fibroblast proliferation surrounding islands of woven bone with characteristic look of a "Chinese letters". The fibroblast show an uniform spindle-shaped nuclei and mitotic figures are not seen. [5, 8] FD shows variable radiographic features in relation with the level of maturation, which determines the amount of density. Thus, on plain films, FD may display the following appearances: radiolucent, ground-glass, smoky, cloudy, peau d'orange, finger print, or diffuse sclerosis. [9, 10] A CT bone window displays FD features similar to those exhibited on X ray films, CT attenuation coefficient values, which vary between 34 and 513 Hounsfield units in the different series, in relation with the amount of fibrous and osseous tissue and the rate of bone deposition, leading to three major imaging patterns: lytic or cystic (20%-30%), dense or sclerotic (20%-30%) and mixed or pagetoid (40%-50%). [11] [12] [13] MRI offers greater specificity in neurovascular and ocular involvement and in detection of other soft tissue lesions. Generally, FD shows an isointense signal on T1 sequence images and a hypointense signal on T2-weighted images. The hypointense signal intensity on T2 sequence images is caused by the osseous deposit. In the first stages of FD, there may be areas of hyperintensity on T2-weighted images. [10, 11, 14] The differential diagnosis of Craniofacial FD must include ossifying fibroma, histiocytosis, Paget's disease, aneurismal bone cyst, central giant cell granuloma, hemangioma, meningioma, eosinophilic granuloma and brown tumor of hyperparathyroidism. [6, 15] The rate of variation to malignant tumor is more high in monostótic craniofacial disease (0.05%). Transformation to Osteosarcoma, fibrosarcoma and chondrosarcoma are the most prevalent malignant tumors reported in the literature. [6] The treatment of craniofacial FD should be focused on the relief of cosmetic and functional problems, which can range from an observational conduct, medical treatment with bisphosphonates, to aggressive surgery. Regular follow-up is required for early detection of disease progression to a malignant transformation. [16] Studies demonstrated that Denosumab, fully-humanized monoclonal antibody to RANKL recently approved for treatment of osteoporosis and skeletalrelated events in adults with bone metastases from solid tumors, was effective for both prevention of lesion expansion and FD-related bone pain. [17] 4. CONCLUSIONS Polyostotic craniofacial FD may rarely involve both sides of the cranium, be no symptoms or may present with different neurological signs. The diagnosis depends mainly on the Imaging exams (X ray, CT or CBCT) but clinicians must be aware of the potential diagnosis even if no symptoms are observed. The treatment, in most cases, is conservative, surgery is only is indicated in cases with marked facial deformity or neurological complications.
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